Using a gamified rehabilitation sy… for Parkinson's (NCT06730074)
Improve seated motor cognitive function
- Trial ID
- NCT06730074
- Official Title
- A Novel Robotic System for Motor-cognitive Exercise for Patients With Parkinson's Disease
- Goal
- Improve seated motor cognitive function
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Adi Negev-Nahalat Eran
- Study Type
- INTERVENTIONAL
- Enrollment
- 15 participants
- Conditions
- Parkinson Disease, Idiopathic
- Interventions
- Using a gamified rehabilitation system in a sitting position involving robots and music for the benefit of individuals with Parkinson's disease (PD)
Summary For Families
The goal is to see if a seated, robot-assisted, gamified exercise program with music can improve motor control and cognitive-motor skills that often worsen in Parkinson's, like hand coordination, timing, and dual-tasking. Participants will use robotic devices that guide and resist upper-limb movements while music and game feedback provide rhythm and attention cues, with precise sensors to retrain movement patterns and keep people motivated; it is a non-drug rehabilitation tool meant to complement medications like levodopa rather than replace them. The study is looking for Hebrew-speaking adults aged 50 to 75 with idiopathic Parkinson's at Hoehn and Yahr stage 3 or below, a MoCA score of 23 or higher, and no major upper-limb orthopedic issues or uncorrected vision or hearing problems.
Locations
- Adi Negev, Ofakim, South, Israel
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Using a gamified rehabilitation system in a sitting position involving robots and music for the benefit of individuals with Parkinson's disease (PD). The goal is to see if a seated, robot-assisted, gamified exercise program with music can improve motor control and cognitive-motor skills that often worsen in Parkinson's, like hand coordination, timing, and dual-tasking. Participants will use robotic devices that guide and resist upper-limb movements while music and game feedback provide rhythm and attention cues, with precise sensors to retrain movement patterns and keep people motivated; it is a non-drug rehabilitation tool meant to complement medications like levodopa rather than replace them. The study is looking for Hebrew-speaking adults aged 50 to 75 with idiopathic Parkinson's at Hoehn and Yahr stage 3 or below, a MoCA score of 23 or higher, and no major upper-limb orthopedic issues or uncorrected vision or hearing problems.
- Who can participate?
- Participants must be between 50 Years and 75 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 3 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- Everyone in this trial receives the experimental treatment. There is no placebo group.
- How many visits does this trial involve?
- Each patient will have five in-person sessions, each lasting 30 minutes.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: Questionnaires & surveys (non-invasive). Confirm the full schedule with the study coordinator.